Windtree Therapeutics Inc
WINT
WINT was delisted on the 4th of May, 2017.
34 hedge funds and large institutions have $5.92M invested in Windtree Therapeutics Inc in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 21 closing their positions.
16,700% more call options, than puts
Call options by funds: $336K | Put options by funds: $2K
3.59% less ownership
Funds ownership: 47.03% → 43.44% (-3.6%)
36% less funds holding
Funds holding: 53 → 34 (-19)
47% less capital invested
Capital invested by funds: $11.2M → $5.92M (-$5.31M)
55% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 20
90% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$90.4K |
| 2 |
RFS
Rockefeller Financial Services
New York
|
+$59.4K |
| 3 |
Renaissance Technologies
New York
|
+$52.5K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$30.2K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$27.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Laurion Capital Management
New York
|
-$278K |
| 2 |
Millennium Management
New York
|
-$213K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$153K |
| 4 |
D.E. Shaw & Co
New York
|
-$31K |
| 5 |
SC
Searle & Co
Greenwich,
Connecticut
|
-$29K |
WINT Hedge Fund Activity: Q1 2016 in Review
34 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q1 2016, worth a combined $5.92M — down 47% from $11.2M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of WINT and 2 opened new positions — a net loss of 19 holders — while 20 trimmed existing stakes and 9 added.
The largest buyer was Sabby Management, adding an estimated $90.4K. The largest seller was Laurion Capital Management, exiting entirely with an estimated $278K sold.
- 34 institutional investors held Windtree Therapeutics Inc (WINT) as of Q1 2016, down from 53 in Q4 2015.
- Funds reported $5.92M of Windtree Therapeutics Inc stock for Q1 2016, down 47% quarter-over-quarter.
- 2 funds opened new Windtree Therapeutics Inc positions in Q1 2016 and 21 closed out, a net change of -19 holders.
- The largest Windtree Therapeutics Inc buyer in Q1 2016 was Sabby Management, an estimated $90.4K added.
- The largest Windtree Therapeutics Inc seller in Q1 2016 was Laurion Capital Management, an estimated $278K sold.
Based on aggregated 13F filings for Q1 2016.